SIGA TECHNOLOGIES INC — Director's Dealing 2008

Nov 17, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGA TECHNOLOGIES INC (SIGA)
CIK: 0001010086
Period of Report: 2008-11-14

Reporting Person: ROSE ERIC A MD (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-11-14	Stock Option (Right to buy)	$2.49	A	400000	Acquired	2018-11-14	Common Stock, par value $.0001 per share (400000)	Direct

Footnotes

F1: The options with respect to 100,000 shares will vest pro rata on the first, second and third anniversaries of the date of grant. The options with respect to the remaining 300,000 shares will vest upon achievement of certain milestones.

F2: Includes 1,020,000 shares of common stock issuable upon exercise of options. Does not include shares of common stock that Dr. Rose, as a director of TransTech Pharma, may be deemed to beneficially own and as to which Dr. Rose disclaims beneficial ownership.